Search Results - "BONDANZA, Attilio"

Refine Results
  1. 1

    Clinical development of CAR T cells—challenges and opportunities in translating innovative treatment concepts by Hartmann, Jessica, Schüßler‐Lenz, Martina, Bondanza, Attilio, Buchholz, Christian J

    Published in EMBO molecular medicine (01-09-2017)
    “…Chimeric antigen receptor (CAR) T cell therapy, together with checkpoint inhibition, has been celebrated as a breakthrough technology due to the substantial…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients by Arcangeli, Silvia, Falcone, Laura, Camisa, Barbara, De Girardi, Federica, Biondi, Marta, Giglio, Fabio, Ciceri, Fabio, Bonini, Chiara, Bondanza, Attilio, Casucci, Monica

    Published in Frontiers in immunology (19-06-2020)
    “…Chimeric antigen receptor (CAR) T cell expansion and persistence emerged as key efficacy determinants in cancer patients. These features are typical of…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene by Casucci, Monica, Falcone, Laura, Camisa, Barbara, Norelli, Margherita, Porcellini, Simona, Stornaiuolo, Anna, Ciceri, Fabio, Traversari, Catia, Bordignon, Claudio, Bonini, Chiara, Bondanza, Attilio

    Published in Frontiers in immunology (21-03-2018)
    “…Chimeric antigen receptor (CAR)-T cell immunotherapy is at the forefront of innovative cancer therapeutics. However, lack of standardization of cellular…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Stability of human rapamycin-expanded CD4+CD25+ T regulatory cells by TRESOLDI, Eleonora, DELL'ALBANI, Ilaria, STABILINI, Angela, JOFRA, Tatiana, VALLE, Andrea, GAGLIANI, Nicola, BONDANZA, Attilio, GRAZIA RONCAROLO, Maria, BATTAGLIA, Manuela

    Published in Haematologica (Roma) (01-09-2011)
    “…The clinical use of ex vivo-expanded T-regulatory cells for the treatment of T-cell-mediated diseases has gained increasing momentum. However, the recent…”
    Get full text
    Journal Article
  13. 13

    Suicide gene therapy to increase the safety of chimeric antigen receptor-redirected T lymphocytes by Casucci, Monica, Bondanza, Attilio

    Published in Journal of Cancer (01-01-2011)
    “…Chimeric antigen receptors (CARs) are generated by fusing the antigen-binding motif of a monoclonal antibody (mAb) with the signal transduction machinery of…”
    Get full text
    Journal Article
  14. 14

    432 Pharmacological inhibition with anti-CD38 mAb protects NK-mediated off-the-shelf CAR T cells allorejection by Rhoo, Jules, Steinhardt, James, Davies, Owanaemi, Simon, Carl, Bondanza, Attilio, Moody, Gordon, Cobbold, Mark, Carlesso, Gianluca, Vian, Laura

    Published in Journal for immunotherapy of cancer (01-11-2023)
    “…BackgroundAutologous CAR-T therapy has revolutionized the treatment of multiple myeloma (MM), but many patients still face obstacles in accessing these…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival by Di Lullo, Giulia, Marcatti, Magda, Heltai, Silvia, Brunetto, Emanuela, Tresoldi, Cristina, Bondanza, Attilio, Bonini, Chiara, Ponzoni, Maurilio, Tonon, Giovanni, Ciceri, Fabio, Bordignon, Claudio, Protti, Maria Pia

    Published in Oncoimmunology (01-05-2015)
    “…There is increased production of plasmacytoid dendritic cells (pDCs) in the bone marrow (BM) of multiple myeloma (MM) patients and these favor Th22 cell…”
    Get full text
    Journal Article
  20. 20

    ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially by Vantaggiato, Chiara, Formentini, Ivan, Bondanza, Attilio, Bonini, Chiara, Naldini, Luigi, Brambilla, Riccardo

    “…The mitogen-activated protein (MAP) kinases p44ERK1 and p42ERK2 are crucial components of the regulatory machinery underlying normal and malignant cell…”
    Get full text
    Journal Article